Cargando…
Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome
BACKGROUND: Gastric cancer remains a serious health concern worldwide. Patients would greatly benefit from the discovery of new biomarkers that predict outcome more accurately and allow better treatment and follow-up decisions. Here, we used a retrospective, observational study to assess the express...
Autores principales: | Camilo, Vânia, Barros, Rita, Celestino, Ricardo, Castro, Patrícia, Vieira, Joana, Teixeira, Manuel R, Carneiro, Fátima, Pinto-de-Sousa, João, David, Leonor, Almeida, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210532/ https://www.ncbi.nlm.nih.gov/pubmed/25300947 http://dx.doi.org/10.1186/1471-2407-14-753 |
Ejemplares similares
-
Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa
por: Barros, Rita, et al.
Publicado: (2016) -
CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype
por: Barros, Rita, et al.
Publicado: (2010) -
Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients
por: Ribeirinho-Soares, Sara, et al.
Publicado: (2021) -
Immunohistochemical Expression of CDX2 in Gastric Carcinoma
por: Sardar, Ahmed Avan, et al.
Publicado: (2022) -
Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2
por: Lopes, Nair, et al.
Publicado: (2019)